Syracuse University

Open enrollment with an early-phase pipeline tilt

According to ClinicalTrials.gov-derived indexes, Syracuse University sits in the top decile of US sponsors by registered trial count (#526 of 15,742 sponsors by registered trial count).

31 total trials 8 currently recruiting 23 completed early-phase tilt top decile by trial count

Syracuse University: 31 sponsored US clinical trials, 8 recruiting.

Syracuse University sponsors 31 registered US clinical trials on ClinicalTrials.gov, 8 of them currently recruiting, and 23 completed. 0 of these trials are in Phase 3-4 (later-stage) and 8 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Speech Sound Disorder, with 4 trials.

Top-decile sponsor footprint

Syracuse University ranks in the top decile of sponsors by registered trial count (#526 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Trial completion reliability score

A 90/100

23 of 23 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (100.0%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.

Open and recent trials

31 total, page 1 of 1

RECRUITING NA

Brain Stimulation Effects on Post-Stroke Fatigue and Aphasia

NCT07151677

RECRUITING NA

Treatment for /s/ Production Errors in Children With Speech Sound Errors

NCT07214480

RECRUITING NA

Evaluating the Effectiveness of Hybrid and Traditional Speech Therapy for /ɹ/ and /s/ Sound Production

NCT07061730

RECRUITING NA

Acceptance and Commitment Therapy for HIV+ Hazardous Drinkers

NCT06648629

RECRUITING NA

AI-Assisted Treatment for Residual Speech Sound Disorders

NCT05988515

RECRUITING NA

Effects of HIIT vs. TRE on Type 2 Diabetes Risk

NCT07215533

RECRUITING Phase 1

Intensive Speech Motor Chaining Treatment for Residual Speech Sound Disorders

NCT05929859

RECRUITING NA

HIIT Effects on Cardiometabolic Health

NCT05838950

COMPLETED NA

Boosting COVID-19 Vaccination Uptake Using Wastewater Surveillance

NCT06698497

COMPLETED NA

Effects of Self-Compassion Practice on Stress Reactivity Among Sexual Minority Women

NCT05949060

COMPLETED NA

A Digital Resilience Intervention for Emergency Medical Service Workers

NCT06861400

COMPLETED NA

Project QueST 2023: Queer Survivors of Trauma

NCT05569915

COMPLETED NA

Wastewater Surveillance to Boost COVID-19 Vaccine Uptake

NCT05766189

COMPLETED NA

Personalized Feedback Intervention for Alcohol and Opioid Use Among Adults With Chronic Pain

NCT04592978

COMPLETED NA

Improving Aphasia Using Electrical Brain Stimulation

NCT04963803

COMPLETED NA

Effects of Emotional Processes on Speech Motor Control in Early Childhood Stuttering.

NCT05003583

COMPLETED NA

The Effects of Respiratory Training on Voice

NCT04710862

COMPLETED NA

10+10+30 Infant Vaccines Communication Via Radio in Ethiopia

NCT04913714

COMPLETED NA

Brief Acceptance and Commitment Therapy for HIV-infected At-risk Drinkers

NCT03974061

COMPLETED Phase 1

The Alcohol-Pain Connection: Mechanisms and Genetic/Psychological Correlates

NCT03311594

COMPLETED NA

Treating Childhood Apraxia of Speech

NCT03238677

COMPLETED NA

Increasing Cessation Motivation and Treatment Engagement Among Smokers in Pain

NCT03996902

COMPLETED Phase 1

Alcohol and Implicit Process in Sexual Risk Behavior in MSM

NCT03361384

COMPLETED NA

Syracuse University Fit Families Program: Autism

NCT02940899

COMPLETED Phase 2

An Examination of the Efficacy of a Self-Determination Theory and Motivational Interviewing Exercise Intervention

NCT02250950

COMPLETED NA

The Effect of Whey Protein Supplementation on Vascular and Cognitive Function in Older Adults

NCT01956994

COMPLETED Phase 1

Effects of Octanoic Acid for Treatment of Essential Voice Tremor

NCT01864525

COMPLETED

Adult Sexual Risk Behavior Among Women With a History of Childhood Sexual Abuse

NCT00653575

COMPLETED Phase 2

Human Papillomavirus (HPV) Vaccination Acceptance by African-American Parents: Identifying Psychosocial Barriers

NCT00680147

COMPLETED Phase 2

Substance Use Risk Education (SURE) Project

NCT00289965

COMPLETED Phase 2

Expressive Writing for Reducing Stress and Diabetic Symptoms in Diabetes Patients

NCT00233142

What is open in the Syracuse University pipeline

8 recruiting of 31 indexed (26% open); 23 completed (74%).

Phase mix: 0 late (III/IV) vs 8 early (I/II) (early-phase heavy).

Top condition: Speech Sound Disorder (4 trials), 9 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

Syracuse University: open-pipeline peers nationwide

Peers matched on 31 registered trials and 26% open enrollment, not the therapeutic-area sidebar.

Syracuse University sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 0100200300400500 0%10%20%30% Total trials Recruiting share Syracuse UniversityChildren's Hospitals and Clinics of MinnesotaCook Group IncorporatedCytokineticsHalozyme TherapeuticsHackensack Meridian HealthShirley Ryan AbilityLabUniversity Health Network, TorontoRutgers, The State University of New Jersey
Syracuse University sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

Syracuse University sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 31 trials (± recruiting share)

Sponsors near 26% open enrollment (± trial volume)

What to do with this Syracuse University page

31 registered trials is a research-attention snapshot, not an endorsement of Syracuse University or any single study.

  • 8 of Syracuse University's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
  • Speech Sound Disorder is the condition Syracuse University studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Speech Sound Disorder trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Syracuse University pipeline card: 31 registered trials from official public datasets.Report a data error.